Discussed On
Episodes
The a16z Show · Mar 9, 2026
Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity
GLP-1 drugs and obesity treatmentPeptide therapy and gray market sourcingSleep technology and circadian biologyReal-time biomarker monitoringCortisol optimization and stress management
View Analysis